Plasma Sterilizers Market to Surpass USD 1.1 Bn by 2031, Driven by Rising HAIs and Demand for Low-Temperature Sterilization Technologies

The global Plasma Sterilizers Market is poised for steady expansion over the next decade, fueled by growing concerns about infection control and the increasing need for advanced sterilization technologies. Valued at USD 590.0 Mn in 2021, the market is projected to grow at a CAGR of 6.4% from 2022 to 2031, reaching more than USD 1,101 Mn by 2031.

Plasma sterilization has emerged as a reliable alternative to traditional steam sterilization methods, especially for complex and heat-sensitive medical devices. Unlike conventional autoclaves that rely on high temperature and humidity, plasma sterilizers use low-temperature gas plasma-primarily hydrogen peroxide-to effectively eliminate pathogens without damaging delicate instruments. This value-added advantage has significantly expanded their adoption across hospitals, ambulatory surgery centers, and specialized healthcare facilities worldwide.

Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=37715

Key Drivers of Market Growth

Rising Burden of Hospital-Acquired Infections (HAIs)
Hospital-acquired infections remain a critical healthcare challenge globally. HAIs such as central line-associated bloodstream infections, catheter-associated urinary tract infections (UTIs), and ventilator-associated pneumonia (VAP) contribute to high morbidity and mortality rates. Common pathogens include C. difficile, MRSA, Klebsiella, E. coli, Enterococcus, and Pseudomonas species.
According to research published by the National Center for Biotechnology Information (NCBI), out of every 100 hospitalized patients, seven in developed countries and 10 in emerging countries acquire hospital-acquired infections. This alarming statistic underscores the urgent need for robust sterilization protocols.
Growth in Hospitalization Rates

Increasing hospitalization rates-particularly during and after the COVID-19 pandemic-have further intensified the demand for effective sterilization systems. In the U.S., hospitalization levels rose significantly during COVID-19 surges, leading to a 31% rise in infection rates and a 10% increase in mortality in certain phases. Approximately 21%-31% of COVID-19 patients required hospitalization, and 5%-11% needed intensive care during peak periods.
The surge in ICU admissions, isolation wards, and temporary hospitals created unprecedented demand for sterilization equipment, accelerating plasma sterilizer adoption globally.

Preference for Low-Temperature Sterilization
Technologically advanced medical devices-such as endoscopes, robotic surgical instruments, and delicate electronic equipment-are vulnerable to damage under high heat and humidity. Plasma sterilizers offer low-temperature sterilization, preserving the structural and functional integrity of thermo-sensitive devices. This advantage is expected to remain a major growth driver during the forecast period.

Key Players and Industry Leaders

The competitive landscape of the plasma sterilizers market is characterized by strategic collaborations, mergers & acquisitions, and continuous product innovation. Prominent companies operating in the global market include:

• Antonio Matachana, S. A.
• ASP Global Manufacturing GmbH
• Cisa Production S.r.l. Unipersonale
• Getinge AB
• Johnson & Johnson Services, Inc.
• HUMAN MEDITEK CO., LTD.
• Steelco S.p.A.
• STERIS plc
• Tuttnauer
• VitroSteril

These companies are focused on expanding their global footprint, enhancing R&D capabilities, and introducing innovative gas-based sterilization solutions.

Recent Developments

The market has witnessed notable strategic developments:

• In April 2022, Getinge AB partnered with the International Finance Corporation (IFC) under the Africa Medical Equipment Facility (AMEF) initiative to improve access to critical medical equipment across Africa.

• In June 2021, STERIS plc completed the acquisition of Cantel Medical, strengthening its infection prevention portfolio across endoscopy, dental, dialysis, and life sciences sectors.

• In February 2022, Cisa Production S.r.l. Unipersonale reopened its U.S. branch and enhanced focus on laboratory sterilization solutions.
These strategic initiatives are expected to intensify competition and drive innovation within the industry.

New Opportunities and Challenges

Opportunities
1. Expansion into Emerging Markets: Growing healthcare infrastructure in Asia Pacific, Latin America, and Africa presents substantial growth opportunities.
2. Inert Gas-Based Plasma Sterilizers: Investment in nitrogen (NO2), oxygen (O2), helium (He), neon (Ne), argon (Ar), and xenon (Xe)-based plasma sterilizers could unlock new revenue streams.
3. Rising Geriatric Population: Asia Pacific is projected to witness a tripling of its population aged above 60 by 2050, increasing hospitalization and surgical interventions.

Challenges
• High initial installation and maintenance costs.
• Strict regulatory requirements for sterilization validation.
• Competition from ethylene oxide and advanced autoclave technologies.

Market Trends & Innovations

Hydrogen Peroxide Gas Dominance
The hydrogen peroxide gas segment held a substantial share in 2021. Benefits such as no chemical residues, short aeration time, safe handling, and eco-friendliness continue to drive demand.

Compact Sterilizers Gaining Traction
The < 100 L chamber capacity segment accounted for more than 50% of the global market in 2021. These compact units are widely preferred in hospitals, clinics, and ambulatory surgery centers due to their operational efficiency and cost-effectiveness.

Focus on Digital Integration
Manufacturers are increasingly integrating digital monitoring systems, automated validation cycles, and IoT-enabled performance tracking into plasma sterilizers to enhance compliance and efficiency.

Buy this Premium Research Report to explore detailed market trends - https://www.transparencymarketresearch.com/checkout.php?rep_id=37715<ype=S

Market Segmentation

By Chamber Capacity:
• < 100 L
• 100-200 L
• 200 L

By Application:
• Sterilization (largest segment)
• Disinfection
• Others

By Source Gas:
• Hydrogen Peroxide Gas
• Others

By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America dominated the market in 2021 due to technological advancements, strong presence of leading players, and stringent infection control mandates. Meanwhile, Asia Pacific is anticipated to witness robust growth owing to expanding healthcare infrastructure and a rapidly aging population.

Key Trends for the Future

• Growing preference for environmentally safe sterilization technologies
• Increased investments in R&D for multi-gas plasma sterilization systems
• Strategic partnerships between manufacturers and healthcare institutions
• Expansion of sterilization services in outpatient and home healthcare settings
• Strengthening of regulatory compliance frameworks worldwide

Future Outlook

The global plasma sterilizers market is expected to maintain consistent growth through 2031, supported by heightened awareness of infection control and technological innovation. With healthcare systems prioritizing patient safety and sustainability, plasma sterilization is set to become a cornerstone of modern sterilization practices.

Market players that invest in advanced gas technologies, regional expansion, and digital innovation will be well-positioned to capitalize on emerging opportunities.

Important FAQs with Answers

1. How big was the global plasma sterilizers market in 2021?
The market was valued at US$ 590.0 Mn in 2021.

2. How large will the market be by 2031?
It is projected to exceed US$ 1,101 Mn by 2031.

3. What is the expected CAGR from 2022 to 2031?
The market is anticipated to expand at a CAGR of 6.4%.

4. What are the key factors driving market growth?
Rising incidence of hospital-acquired infections, increasing surgical procedures, and growing preference for low-temperature sterilization technologies.

5. Which segment holds the largest share?
The < 100 L chamber capacity segment accounted for more than 50% of the market in 2021.

6. Which region dominates the market?
North America held the largest share in 2021.

7. Who are the leading players?
Major companies include Getinge AB, STERIS plc, Cisa Production S.r.l. Unipersonale, and others.

More Related Reports-

Chromoendoscopy Agents Market: https://www.transparencymarketresearch.com/chromoendoscopy-agents-market.html

Medical Laser Systems Market: https://www.transparencymarketresearch.com/medical-laser-systems-market.html

Renal Denervation Devices Market: https://www.transparencymarketresearch.com/renal-denervation-devices-market.html

Endovascular Treatment Devices Market: https://www.transparencymarketresearch.com/endovascular-treatment-devices-market.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.